![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 25, 26266-26273, June 18, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





||
From the
Center for Molecular and Vascular Biology and the ¶Laboratory of Morphology and Molecular Pathology, University of Leuven, 3000 Leuven, Belgium
Shear stress triggers von Willebrand factor (VWF) binding to platelet glycoprotein Ib
and subsequent integrin
IIb
3-dependent platelet aggregation. Concomitantly, nucleotides are released from plateletdense granules, and ADP is known to contribute to shear-induced platelet aggregation (SIPA). We found that the impaired SIPA of platelets from a Hermansky-Pudlak patient lacking dense granules was restored by exogenous L-
,
-methylene ATP, a stable P2X1 agonist, as well as by ADP, confirming that in addition to ADP (via P2Y1 and P2Y12), ATP (via P2X1) also contributes to SIPA. Likewise, SIPA of apyrase-treated platelets was restored upon P2X1 activation with L-
,
-methylene ATP, which promoted granule centralization within platelets and stimulated P-selectin expression, which is a marker of
-granule release. In addition, during SIPA, platelet degranulation required both extracellular Ca2+ and VWF-glycoprotein Ib
interactions without involving
IIb
3. Neither platelet release nor SIPA was affected by protein kinase C inactivation, even though protein kinase C blockade inhibits platelet responses to collagen and thrombin in stirring conditions. In contrast, inhibiting myosin light chain (MLC) kinase with ML-7 reduced platelet release and SIPA by 30%. Accordingly, the potentiating effect of P2X1 stimulation on the aggregation of apyrase-treated platelets coincided with intensified phosphorylation of MLC and was abrogated by ML-7. SIPA-induced MLC phosphorylation occurred exclusively through released nucleotides and selective antagonism of P2X1 with MRS2159-reduced SIPA, ATP release, and potently inhibited MLC phosphorylation. We conclude that the P2X1 ion channel induces MLC-mediated cytoskeletal rearrangements, thus contributing to SIPA and degranulation during VWF-triggered platelet activation.
Received for publication, February 24, 2004 , and in revised form, April 14, 2004.
* This work was supported by Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO) Project G.0227.03 and by Geconcerteerde Onderzoeksactie/2004/09. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of a postdoctoral research mandate from the FWO.
|| To whom correspondence should be addressed: University of Leuven, Center for Molecular and Vascular Biology, Herestraat 49, 3000 Leuven, Belgium. Tel.: 32-16-346145; Fax: 32-16-345990; E-mail: marc.hoylaerts{at}med.kuleuven.ac.be.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Vial and R. J. Evans Disruption of Lipid Rafts Inhibits P2X1 Receptor-mediated Currents and Arterial Vasoconstriction J. Biol. Chem., September 2, 2005; 280(35): 30705 - 30711. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hechler, S. Magnenat, M. L. Zighetti, M. U. Kassack, H. Ullmann, J.-P. Cazenave, R. Evans, M. Cattaneo, and C. Gachet Inhibition of Platelet Functions and Thrombosis through Selective or Nonselective Inhibition of the Platelet P2 Receptors with Increasing Doses of NF449 [4,4',4'',4'''-(Carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic Acid Octasodium Salt] J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 232 - 243. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |